Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Alan List, MD

Director, Translational and Clinical Research
Moffitt Cancer Center
Member of the Healthcare Council

Alan List, MD, is a Medical Oncologist and serves as Executive Vice President and Physician-in-Chief at the Moffitt Cancer Center in Tampa, Florida. Dr. List is an expert in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Previously, he spent 15 years at the Arizona Cancer Center. Dr. List's research is translational in nature and focuses on the delineation of biological targets in these malignancies, and corresponding development of novel therapeutics. He serves as an advisor or consultant to over a dozen pharmaceutical companies developing therapeutics in AML and MDS. (This is me - Update Profile)


Employment History
2004 - present Director, Translational and Clinical Research
Moffitt Cancer Center
1988 - 2004 Professor
Arizona Cancer Center

GLG Study Groups with Alan List, MD(?)

View All Study Groups with Alan List, MD

GLG NewsSM Analyses by Alan List, MD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Alan List, MD has not published any public GLG News analyses.
View all GLG News in Healthcare

GLG InstituteSM Seminars with Alan List, MD(?)

Request a project with Alan List, MD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics